Article
Limited evolution but increasing trends of primary non-nucleoside reverse transcriptase inhibitor resistance mutations in therapy-naive HIV-1-infected individuals in India.
Antiviral therapy - 1 Jan 2014
Neogi Ujjwal, Gupta Soham, Palchaudhuri Riya, Rao Shwetha D, Shastri Suresh, Diwan Vishal, Laishram Ranbir S, De Costa Ayesha, Shet Anita
Abstract excerpt
BACKGROUND: After the rapid scale-up of antiretroviral therapy (ART) in resource-limited settings, surveillance of primary drug resistance mutations (DRMs) among ART-naive individuals has important public health benefits. Although a highly successful national ART programme initiated by the Government of India exists, data on the prevalence of primary DRMs is scarce. The objective of the study is to estimate the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.